Cargando…

Functional immunity against SARS-CoV-2 in the general population after a booster campaign and the Delta and Omicron waves, Switzerland, March 2022

Functional immunity (defined here as serum neutralising capacity) critically contributes to conferring protection against SARS-CoV-2 infection and severe COVID-19. This cross-sectional analysis of a prospective, population-based cohort study included 1,894 randomly-selected 16 to 99-year-old partici...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amati, Rebecca, Frei, Anja, Kaufmann, Marco, Sabatini, Serena, Pellaton, Céline, Fehr, Jan, Albanese, Emiliano, Puhan, Milo A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2022
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358404/ https://www.ncbi.nlm.nih.gov/pubmed/35929427 http://dx.doi.org/10.2807/1560-7917.ES.2022.27.31.2200561

Ejemplares similares

Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior vaccination: Pooled analysis of two population-based cohorts
por: Ballouz, Tala, et al.
Publicado: (2023)

Longitudinal humoral and cell-mediated immune responses in a population-based cohort in Zurich, Switzerland between March and June 2022 - evidence for protection against Omicron SARS-CoV-2 infection by neutralizing antibodies and spike-specific T-cell responses
por: Zens, Kyra Denise, et al.
Publicado: (2023)

Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022
por: Bastard, Jonathan, et al.
Publicado: (2022)

Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022
por: Huiberts, Anne J, et al.
Publicado: (2023)

Projection of healthcare demand in Germany and Switzerland urged by Omicron wave (January–March 2022)
por: Gorji, Hossein, et al.
Publicado: (2023)

Vaccine-induced and naturally-acquired protection against Omicron and Delta symptomatic infection and severe COVID-19 outcomes, France, December 2021 to January 2022
por: Suarez Castillo, Milena, et al.
Publicado: (2022)

Association between serologically confirmed COVID-19 infection and cognitive functioning in community dwelling older adults
por: Serena, Sabatini, et al.
Publicado: (2023)

Trajectories of Seroprevalence and Neutralizing Activity of Antibodies against SARS-CoV-2 in Southern Switzerland between July 2020 and July 2021: An Ongoing, Prospective Population-Based Cohort Study
por: Amati, Rebecca, et al.
Publicado: (2023)

COVID-19 vaccination and BA.1 breakthrough infection induce neutralising antibodies which are less efficient against BA.4 and BA.5 Omicron variants, Israel, March to June 2022
por: Kliker, Limor, et al.
Publicado: (2022)

Multidrug-resistant organisms in patients from Ukraine in the Netherlands, March to August 2022
por: Zwittink, Romy D, et al.
Publicado: (2022)

Risk of severe COVID-19 from the Delta and Omicron variants in relation to vaccination status, sex, age and comorbidities – surveillance results from southern Sweden, July 2021 to January 2022
por: Kahn, Fredrik, et al.
Publicado: (2022)

Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022
por: Eggink, Dirk, et al.
Publicado: (2022)

SARS-CoV-2 Omicron variants BA.1 and BA.2 both show similarly reduced disease severity of COVID-19 compared to Delta, Germany, 2021 to 2022
por: Sievers, Claudia, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 antibodies, associated factors, experiences and attitudes of nursing home and home healthcare employees in Switzerland
por: West, Erin A., et al.
Publicado: (2022)

Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022
por: Veneti, Lamprini, et al.
Publicado: (2022)

COVID-19 vaccine effectiveness against severe disease from SARS-CoV-2 Omicron BA.1 and BA.2 subvariants – surveillance results from southern Sweden, December 2021 to March 2022
por: Björk, Jonas, et al.
Publicado: (2022)

COVID-19 mRNA vaccine effectiveness (second and first booster dose) against hospitalisation and death during Omicron BA.5 circulation: cohort study based on electronic health records, Portugal, May to July 2022
por: Kislaya, Irina, et al.
Publicado: (2022)

Ongoing toxin-positive diphtheria outbreaks in a federal asylum centre in Switzerland, analysis July to September 2022
por: Kofler, Jacob, et al.
Publicado: (2022)

Associations of multilingualism and language proficiency with cognitive functioning: epidemiological evidence from the SwissDEM study in community dwelling older adults and long-term care residents
por: Pacifico, Deborah, et al.
Publicado: (2023)

mRNA vaccine effectiveness against hospitalisation due to severe acute respiratory infection (SARI) COVID-19 during Omicron variant predominance estimated from real-world surveillance data, Slovenia, February to March 2022
por: Grgič Vitek, Marta, et al.
Publicado: (2022)

Impact of booster vaccination on the control of COVID-19 Delta wave in the context of waning immunity: application to France in the winter 2021/22
por: Bosetti, Paolo, et al.
Publicado: (2022)

Protection against severe COVID-19 after second booster dose of adapted bivalent (original/Omicron BA.4-5) mRNA vaccine in persons ≥ 60 years, by time since infection, Italy, 12 September to 11 December 2022
por: Fabiani, Massimo, et al.
Publicado: (2023)

Risk and protective factors for SARS-CoV-2 reinfections, surveillance data, Italy, August 2021 to March 2022
por: Sacco, Chiara, et al.
Publicado: (2022)

Results of an interventional HIV testing programme in the context of a mpox (formerly monkeypox) vaccination campaign in Latium Region, Italy, August to October 2022
por: Pittalis, Silvia, et al.
Publicado: (2022)

Older adults’ motivations to participate or not in epidemiological research. Qualitative inquiry on a study into dementia in Switzerland
por: Fiordelli, Maddalena, et al.
Publicado: (2021)

A large multi-country outbreak of monkeypox across 41 countries in the WHO European Region, 7 March to 23 August 2022
por: Vaughan, Aisling M, et al.
Publicado: (2022)

Effectiveness of bivalent COVID-19 boosters against COVID-19 mortality in people aged 65 years and older, Australia, November 2022 to May 2023
por: Liu, Bette, et al.
Publicado: (2023)

Shorter serial intervals in SARS-CoV-2 cases with Omicron BA.1 variant compared with Delta variant, the Netherlands, 13 to 26 December 2021
por: Backer, Jantien A, et al.
Publicado: (2022)

Drivers of Acceptance of COVID-19 Proximity Tracing Apps in Switzerland: Panel Survey Analysis
por: von Wyl, Viktor, et al.
Publicado: (2021)

Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022
por: Fonager, Jannik, et al.
Publicado: (2022)

Changes in Healthcare Utilization During the COVID-19 Pandemic and Potential Causes—A Cohort Study From Switzerland
por: Harju, Erika, et al.
Publicado: (2023)

Surveillance and return to work of healthcare workers following SARS-CoV-2 Omicron variant infection, Sheffield, England, 17 January to 7 February 2022
por: Raza, Mohammed, et al.
Publicado: (2022)

Omicron BA.2.75 variant is efficiently neutralised following BA.1 and BA.5 breakthrough infection in vaccinated individuals, Israel, June to September 2022
por: Atari, Nofar, et al.
Publicado: (2022)

Temporal, age, and geographical variation in vaccine efficacy against infection by the Delta and Omicron variants in the community in France, December 2021 to March 2022
por: Blanquart, François, et al.
Publicado: (2023)

Omicron Booster in Ancestral Strain Vaccinated Mice Augments Protective Immunities Against Both Delta and Omicron Variants
por: Jia, Liqiu, et al.
Publicado: (2022)

Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland
por: West, Erin A., et al.
Publicado: (2020)

Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland—A multicentre cohort study
por: Babouee Flury, Baharak, et al.
Publicado: (2022)

The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022
por: Sridhar, Saranya, et al.
Publicado: (2022)

Joys or Sorrows of Parenting During the COVID-19 Lockdown: A Scoping Review
por: Fadda, Marta, et al.
Publicado: (2023)

Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022
por: Sentís, Alexis, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_stlq7sg6canfqp877itfruphcc